CL2013001803A1 -
Compounds derived from bicyclo [3,2,1] octylamide, metabotropic glutamate receptor 5 allosteric modulators; pharmaceutical compositions comprising them; and its use in diseases or disorders of the CNS or in cognitive, neurodegenerative, psychiatric or neurological disorder.
- Google Patents
Compounds derived from bicyclo [3,2,1] octylamide, metabotropic glutamate receptor 5 allosteric modulators; pharmaceutical compositions comprising them; and its use in diseases or disorders of the CNS or in cognitive, neurodegenerative, psychiatric or neurological disorder.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=52014885&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001803(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As HfiledCriticalLundbeck & Co As H
Publication of CL2013001803A1publicationCriticalpatent/CL2013001803A1/en
CL2013001803A2010-12-222013-06-19
Compounds derived from bicyclo [3,2,1] octylamide, metabotropic glutamate receptor 5 allosteric modulators; pharmaceutical compositions comprising them; and its use in diseases or disorders of the CNS or in cognitive, neurodegenerative, psychiatric or neurological disorder.
CL2013001803A1
(en)
Compounds derived from bicyclo [3,2,1] octylamide, metabotropic glutamate receptor 5 allosteric modulators; pharmaceutical compositions comprising them; and its use in diseases or disorders of the CNS or in cognitive, neurodegenerative, psychiatric or neurological disorder.
Compounds derived from 1,3-disubstituted-4-phenyl-1h-pyridin-2-one, allosteric modulators of the glutamatergic receptor mglur2; Pharmaceutical composition and use of the compounds in the treatment of neurological and psychiatric conditions mediated by mglur2.
PYRAZOLOPYRIDINE COMPOUNDS, PIRAZOLOPYRAZINE, PYRAZOLOPYRIMIDINE, PYRAZOLOTHIOPHENE AND PYRAZOLOTHIAZOLE AS MGLUR4 ALLOSTERIC POINTENTIALIZERS, COMPOSITIONS AND METHODS OF TREATMENT OF NEUROLOGICAL DYSFUNCTION
Compounds derived from bicyclic pyridinones and their salts; pharmaceutical composition that includes them; and its use for the treatment of neurodegeneration and psychiatric disorders, which include Alzheimer's disease or Niemann-pick type C disease.
Compounds derived from substituted 2-heteroaryl-6-phenyl-imidazol [1,2-a] pyridines; not receptor modulators; intermediate compounds; preparation procedure; pharmaceutical composition; and use in the treatment of cancer, inflammation, neurodegenerative and psychiatric diseases, epilepsy, among others.
Phenyl-3-aza-bicyclo [3.1.0] hex-3-yl-methanone derivative compounds, glycine transporter inhibitors (glyt1); pharmaceutical composition that contains them; pharmaceutical combination; and its use in the treatment of Alzheimer's disease, cognitive disorders in schizophrenia, psychosis, psychiatric disorders, among others
Compounds derived from substituted 6,7-dialkoxy-3-isoquinolinol, inhibitors of pde10a; pharmaceutical composition that includes them; and its use in the treatment of metabolic disorders, CNS disorders such as Alzheimer's disease, dementia, depression and neurodegenerative disorders such as multiple sclerosis, among others.
Compounds derived from imidazo [1,2-a] pyridine-2-heterocyclyl-methanone, modulators of nuclear receptors nurr1; intermediate compounds; pharmaceutical composition; medicine; and use for the treatment and prevention of neurodegenerative, psychiatric, inflammatory diseases, osteoporosis, cancer, among others.
DERIVATIVES OF 1-HYDROXI-2-OXO-HYDROQUINOLINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME TO TREAT COGNITIVE DEFICITS ASSOCIATED WITH SCHIZOPHRENIA AND OTHER PSYCHIATRIC AND / OR NEUROLOGICAL DISORDERS
Compounds derived from substituted pyrrolidine amides, histamine h3 receptor modulators; pharmaceutical composition containing them; and its use for the treatment of diseases such as dementia, Alzheimer's, cognitive dysfunction, memory disorder, learning disorder, attention deficit, among others.